THE STRUCTURAL AND FUNCTIONAL BASIS FOR THE KIRROMYCIN RESISTANCE OF MUTANT EF-TU SPECIES IN ESCHERICHIA-COLI

被引:59
作者
MESTERS, JR
ZEEF, LAH
HILGENFELD, R
DEGRAAF, JM
KRAAL, B
BOSCH, L
机构
[1] LEIDEN UNIV,DEPT BIOCHEM,2300 RA LEIDEN,NETHERLANDS
[2] HOECHST AG,CENT RES G865A,PROT CRYSTALLOG,D-65926 FRANKFURT,GERMANY
关键词
GTPASE; NUCLEOTIDE DISSOCIATION; PROTEIN BIOSYNTHESIS; PROTEIN; CONFORMATION; TUFA MUTATION;
D O I
10.1002/j.1460-2075.1994.tb06815.x
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
A structural and functional understanding of resistance to the antibiotic kirromycin in Escherichia coli has been sought in order to shed new light on the functioning of the bacterial elongation factor Tu (EF-Tu), in particular its ability to act as a molecular switch. The mutant EF-Tu species G316D, A375T, A375V and Q124K, isolated by M13mp phage-mediated targeted mutagenesis, were studied, In this order the mutant EF-Tu species showed increasing resistance to the antibiotic as measured by poly(U)-directed poly(Phe) synthesis and intrinsic GTPase activities. The K'(d) values for kirromycin binding to mutant EF-Tu.GTP and EF-Tu.GDP increased in the same order. All mutation sites cluster in the interface of domains 1 and 3 of EF-Tu.GTP, not in that of EF-Tu.GDP. Evidence is presented that kirromycin binds to this interface of wildtype EF-Tu.GTP, thereby jamming the conformational switch of EF-Tu upon GTP hydrolysis. We conclude that the mutations result in two separate mechanisms of resistance to kirromycin. The first inhibits access of the antibiotic to its binding site on EF-Tu.GTP. A second mechanism exists on the ribosome, when mutant EF-Tu species release kirromycin and polypeptide chain elongation continues.
引用
收藏
页码:4877 / 4885
页数:9
相关论文
共 55 条
[41]   GENETIC-ENGINEERING, ISOLATION AND CHARACTERIZATION OF A TRUNCATED ESCHERICHIA-COLI ELONGATION-FACTOR TU COMPRISING DOMAIN-2 AND DOMAIN-3 [J].
PIEPER, U ;
EHBRECHT, HJ ;
FLIESS, A ;
SCHICK, B ;
JURNAK, F ;
PINGOUD, A .
BIOCHIMICA ET BIOPHYSICA ACTA, 1990, 1087 (02) :147-156
[42]  
PINGOUD A, 1982, J BIOL CHEM, V257, P1261
[43]   A H-1-NMR STUDY OF THE ESCHERICHIA-COLI ELONGATION-FACTOR-TU WITH GUANINE-NUCLEOTIDES AND THE ANTIBIOTIC KIRROMYCIN [J].
ROMER, R ;
BLOCK, W ;
PINGOUD, A ;
WOLF, H .
FEBS LETTERS, 1981, 126 (02) :161-164
[44]  
ROSENTHAL LP, 1987, J BIOL CHEM, V262, P10955
[45]   HOW DOES THE SWITCH-II REGION OF G-DOMAINS WORK [J].
STOUTEN, PFW ;
SANDER, C ;
WITTINGHOFER, A ;
VALENCIA, A .
FEBS LETTERS, 1993, 320 (01) :1-6
[46]  
VANDERMEIDE PH, 1981, EUR J BIOCHEM, V117, P1
[47]  
VANNOORT JM, 1984, P NATL ACAD SCI-BIOL, V81, P3969
[48]  
VIJGENBOOM E, 1989, J BIOL CHEM, V264, P13012
[49]   MECHANISM OF INHIBITION OF PROTEIN-SYNTHESIS BY KIRROMYCIN - ROLE OF ELONGATION FACTOR-TU AND RIBOSOMES [J].
WOLF, H ;
CHINALI, G ;
PARMEGGIANI, A .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1977, 75 (01) :67-75
[50]   KIRROMYCIN, AN INHIBITOR OF PROTEIN-BIOSYNTHESIS THAT ACTS ON ELONGATION-FACTOR TU [J].
WOLF, H ;
CHINALI, G ;
PARMEGGIANI, A .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1974, 71 (12) :4910-4914